FDA approves Cepheid test for S aureas, MRSA.
GENOME

Cepheid disclosed on 8 Jun 2010 that the US Food and Drug Administration has approved its Xpert SA Nasal Complete test. The molecular diagnostic product can identify and differentiate Staphylococcus aureas and Methicillin-resistant Staphylococccus aureus (MRSA) colonization and provide results in less than 1 hr. Cepheid will start offering the test in Jul 2010. Xpert SA Nasal Complete runs on Cepheid’s GeneXpert system.

Lee Ann Torrans

ltorrans@gmail.com

Comments

No one has said anything yet.

Comments are closed.

© Copyright . All Rights Reserved.